gout medicamentation

Amgen-Horizon Deal under Intense Scrutiny

Amgen’s proposed acquisition of Horizon Therapeutics for $28.7 billion, including debt, would be the largest healthcare deal since AstraZeneca’s $39 billion purchase of Alexion in 2021, if it goes ahead. As such, it is under intense scrutiny.

US Approves AstraZeneca’s Zurampic Gout Drug

Astra Fuels Biotech M&A with $1.3 bln Ardea Buy